Identification and characterization of a new growth hormone-releasing peptide receptor in the heart

Circulation Research

Volumn 85, Issue 9, 1999, Pages 796-802

  Bodart, V ^a   Bouchard, J F ^a   McNicoll, N ^a   Escher, E ^b   Carriere P ^a   Ghigo, E ^e   Sejlitz, T ^c   Sirois, M G ^d   Lamontagne, D ^a   Ong, H ^a  

^a UNIVERSITÉ DE MONTRÉAL   (Canada)

^b UNIVERSITÉ DE SHERBROOKE   (Canada)

^c PFIZER INC   (United States)

^d MONTREAL HEART INSTITUTE   (Canada)

^e Succursale Centre Ville ^*

Author keywords

Growth hormone releasing peptide; Heart; Langendorff perfused heart; Photoaffinity labeling; Receptor

Indexed keywords

BISINDOLYLMALEIMIDE; CALCIUM CHANNEL; CHELERYTHRINE; DICLOFENAC; GROWTH HORMONE RECEPTOR; GROWTH HORMONE RELEASING FACTOR; HEXARELIN; IBUTAMOREN; IMIDAZOLE DERIVATIVE; NIFEDIPINE; PROSTAGLANDIN; PROTEIN KINASE C; THROMBOXANE;

ANIMAL TISSUE; ARTICLE; BINDING SITE; CONTROLLED STUDY; CORONARY ARTERY BLOOD FLOW; CORONARY VASCULAR RESISTANCE; HEART; HEART PERFUSION; ISOLATED HEART; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; RAT; VASOCONSTRICTION;

EID: 0032725129     PISSN: 00097330     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.RES.85.9.796     Document Type: Article

References (29)

1. Ghigo E, Arvat E, Muccioli G, Camanni F. Growth hormone-releasing peptides. Eur J Endocrinol. 1997;136:445-460.
2. Nargund RP, Van der Ploeg HT. Growth hormone secretagogues. In: Hagmann WK, ed. Annual Reports in Medicinal Chemistry. New York, NY: Academic Press; 1997:221-230.
3. Smith RG, Van der Ploeg LHT, Howard AD, Feighner SD, Cheng K, Hickey GJ, Wyvratt MJ Jr, Fisher MH, Nargund RP, Patchett AA. Peptidomimetic regulation of growth hormone secretion. Endocr Rev. 1997;18:621-645.
4. Locatelli V, Torsello A. Growth hormone secretagogues: focus on the growth hormone-releasing peptides. Pharmacol Res. 1997;36:415-423.
5. Howard AD, Feighner SD, Cully DF, Arena JP, Liberator PA. Rosenblum CI, Hamelin M, Hreniuk DL, Palyha OC, Anderson J, Paress PS, Diaz C, Chou M, Liu KK, McKee KK, Pong SS, Chaung LY, Elbrecht A, Dashkevicz M, Heavens R, Rigby M, Sirinathsinghji DJS, Dean DC, Melillo DG, Van der Ploeg LH, et al. A receptor in pituitary and hypothalamus that functions in growth hormone release. Science. 1996;273:974-977.
6. McKee KK, Palyha OC, Feighner SD, Hreniuk DL, Tan CP, Phillips MS, Smith RG, Van der Ploeg LH, Howard AD. Molecular analysis of rat pituitary and hypothalamic growth hormone secretagogue receptors. Mol Endocrinol. 1997;1:415-423.
7. Hreniuk DL, Nargund R, Underwood D, Tata JR, Dean DC, Tan CP, McKee KK, Woods JW, Patchett AA, Smith RG, Van der Ploeg LH. Structural requirements for the activation of the human growth hormone secretagogue receptor by peptide and non peptide secretagogues. Mol Endocrinol. 1998;12:137-145.
8. Ong H, McNicoll N, Escher E, Collu R, Deghenghi R, Locatelli V, Ghigo E, Muccioli G, Boghen M, Nilsson M. Identification of a pituitary growth hormone-releasing peptide (GHRP) receptor subtype by photoaffinity labeling. Endocrinology. 1998;139:432-435.
9. De Gennaro Colonna V, Rossoni G, Bernareggi M, Muller EE, Berti F. Cardiac ischemia and impairment of vascular endothelium function in hearts from growth hormone-deficient rats: protection by hexarelin. Eur J Pharmacol. 1997;334:201-207.
10. Rossoni G, De Gennaro Colonna V, Bernareggi M, Polvani GL, Müller EE, Berti F. Protectant activity of hexarelin or growth hormone against postischemic ventricular dysfunction in hearts from aged rats. J Cadiovasc Pharmacol. 1998;32:260-265.
11. Mathews LS, Enberg B, Norstedt G. Regulation of rat growth hormone receptor gene expression. J Biol Chem. 1989;264:9905-9910.
12. Guse AH, Kiess W, Funk B, Kessler U, Berg I, Gercken G. Identification and characterization of insulin-like growth factor receptors on adult rat cardiac myocytes: linkage to inositol 1, 4. 5-trisphosphate formation. Endocrinology. 1992;130:145-151.
13. Bouchard JF, Lamontagne D. Mechanisms of protection afforded by preconditioning to endothelial function against ischemic injury. Am J Physiol. 1996;271:H1801-H1806.
14. Harigaya S, Schwartz A. Rate of calcium binding and uptake in normal animal and failing human cardiac muscle. Circ Res. 1969;25:781-794.
15. De Léan A, Hancock AA, Lefkowilz RJ. Validation and statistical analysis of a computer modeling method for quantitative analysis of radioligand binding data for mixtures of pharmacological receptor subtypes. Mol Pharmacol. 1982;21:5-16.
16. De Léan A, Munson PJ, Rodbard D. Simultaneous analysis of families of sigmoidal curves: application to bioassay, radioligand assay and physiological dose-response curves. Am J Physiol. 1978;235:E97-E102.
17. Herbert JM, Augereau JM, Gleye J, Maffrand JP. Chelerythrine is a potent and specific inhibitor of protein kinase C. Biochem Biophys Res Commun. 1990;172:993-999.
18. Toullec D, Pianetti P, Coste H, Bellevergue P, Grand-Perret T, Ajakane M, Baudet V, Boissin P, Boursier E, Loriolle F, Duhamel L, Charon D, Kirilovsky J. The bisindolylmaleimide GF 109203X is a potent and selective inhibitor of protein kinase C. J Biol Chem. 1991;266: 15771-15781.
19. Yoshimoto T, Yamamoto S, Hayaishi O. Selective inhibition of prostaglandin endoperoxide thromboxane isomerase by 1-carboxyalkylimidazoles. Prostaglandins. 1978;16:529-540.
20. Gulbenkin S, Edvinsson L, Saetrum Opgaard O, Wharton J, Polak JM, David-Ferreira JF. Peptide-containing nerve fibres in guinea-pig coronary arteries: immunohistochemistry, ultrastructure and vasomotility. J Auton Nerv Syst. 1990;31:153-168.
21. Neubauer S, Ertl G, Haas U, Pulzer F, Kochsick K. Effects of endothelin-1 in isolated perfused heart. J Cardiovasc Pharmacol. 1990;16:1-8.
22. Sechi LA, Griffin CA, Grady EF, Kalinyak JE, Schambelan M. Characterization of angiotensin II receptor subtypes in rat heart. Circ Res. 1992;71:1482-1489.
23. 2-vasopressinergic receptors. Am J Physiol. 1988;255:H261-H265.
24. Hollenberg MD. The acute actions of growth factors in smooth muscle systems. Life Sci. 1994;54:223-235.
25. Pong SS, Chaung LVP, Dean DC, Nargund RP, Patchett AA, Smith RG. Identification of a new G-protein linked receptor for growth hormone secretagogues. Mol Endocrinol. 1996;10:57-61.
26. Sethumadhavan K, Veeraragavan K, Bowers CY. Demonstration and characterization of the specific binding of growth hormone-releasing peptide to rat anterior pituitary and hypothalamic membranes. Biochem Biophys Res Comm. 1991;178:31-37.
27. Dorman G, Prestwich GD. Benzophenone photophores in biochemistry. Biochemistry. 1994;33:5661-5673.
28. Duerr RL, McKirnan MD, Gim RD, Clark RG, Chien KR, Ross J Jr. Cardiovascular effects of insulin-like growth factor-1 and growth hormone in chronic left ventricular failure in the rat. Circulation. 1996; 93:2188-2196.
29. Osterziel KJ, Strohm O, Schuler J, Friedrich M, Hanlein D, Willenbrock R, Anker SD, Poole-Wilson PA, Ranke MB, Dietz R. Randomised, double-blind, placebo-controlled trial of human recombinant growth hormone in patients with chronic heart failure due to dilated cardiomyopathy. Lancet. 1998;351:1233-1237.